Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
34.8M
-
Shares change
-
-82K
-
Total reported value, excl. options
-
$2B
-
Value change
-
-$4.71M
-
Put/Call ratio
-
0.51
-
Number of sells
-
-3
-
Price
-
$57.49
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2013
135 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2013.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.8M shares
of 44.9M outstanding shares and own 77.64% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (4.77M shares), GILDER GAGNON HOWE & CO LLC (3.85M shares), FMR LLC (3.68M shares), JENNISON ASSOCIATES LLC (2.77M shares), VANGUARD GROUP INC (1.8M shares), DARUMA CAPITAL MANAGEMENT LLC (1.3M shares), ALLIANCEBERNSTEIN L.P. (1.3M shares), BlackRock Fund Advisors (1.21M shares), Visium Asset Management, LP (1.14M shares), and State Street Corp (970K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.